| Trial ID: | L0368 |
| Source ID: | JPRN-jRCTs041210149
|
| Associated Drug: |
PPE
|
| Title: |
Effect of pig placenta extract (PPE) supplementation on nonalcoholic fatty liver disease - Pilot study -
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease
|
| Interventions: |
Pig placenta extract (JBP porcine 100: 350mg/capsule),orally administered 6 Capsules/day for24 weeks
|
| Outcome Measures: |
AST (aspartate aminotransferase) and ALT (alanine transferase) before treatment and at 12, and 24 weeks of treatmentCLDQ, BMI, type IV collagen, hyaluronic acid, CT values, and liver stiffness before and at 24 weeks of treatment
|
| Sponsor/Collaborators: |
Mutsumi Tsuchishima
|
| Gender: |
All
|
| Age: |
>= 20age old<= 75age old
|
| Phases: |
Phase 1
|
| Enrollment: |
10
|
| Study Type: |
Interventional
|
| Study Designs: |
single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
|
| Start Date: |
18/02/2022
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
1 March 2022
|
| Locations: |
Japan
|
| URL: |
https://jrct.niph.go.jp/latest-detail/jRCTs041210149
|
